Our results demonstrate that AMP-independent allosteric activation of AMPK ameliorates both the energy depletion and oxidative stress arising from mitochondrial dysfunction and provide support for these compounds as attractive candidates for treating mitochondrial disease. This evidence concerns the gene PRKAA1 and inborn mitochondrial metabolism disorder.